GlassScriptPhysician profile
Sheena C Painter
NPI 1760834378
$770.25
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $366 · 2022: $404.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $142.82 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $92.85 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $87.96 | 2021-2022 | |
| Abbvie INC. | $63.96 | 2021-2022 | |
| Abbott Laboratories | $59.45 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $50.67 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $39.89 | 2022 | |
| Novartis Pharmaceuticals Corporation | $38.89 | 2021-2022 | |
| Pfizer INC. | $33.18 | 2022 | |
| Apria Healthcare LLC | $28.39 | 2021 | |
| Eisai INC. | $28.25 | 2021-2022 | |
| Amgen INC. | $28.02 | 2022 | |
| Advanced Respiratory, INC | $18.88 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.53 | 2021 | |
| Lilly USA, LLC | $15.13 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $13.05 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $12.33 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheena Painter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.